| 000 | 01281 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513183739.0 | ||
| 264 | 0 | _c19990803 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0968-0896 | ||
| 024 | 7 |
_a10.1016/s0968-0896(99)00009-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrady, K D | |
| 245 | 0 | 0 |
_aA catalytic mechanism for caspase-1 and for bimodal inhibition of caspase-1 by activated aspartic ketones. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _cApr 1999 |
||
| 300 |
_a621-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCaspase 1 _xchemistry |
| 650 | 0 | 4 | _aCaspase Inhibitors |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aKetones _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGiegel, D A | |
| 700 | 1 | _aGrinnell, C | |
| 700 | 1 | _aLunney, E | |
| 700 | 1 | _aTalanian, R V | |
| 700 | 1 | _aWong, W | |
| 700 | 1 | _aWalker, N | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 7 _gno. 4 _gp. 621-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0968-0896(99)00009-7 _zAvailable from publisher's website |
| 999 |
_c10312283 _d10312283 |
||